Dr. Jeff Settleman, Ph.D., Chief Scientific Officer, Oncology Research and Development, Pfizer
Advertisement
Articles by Dr. Jeff Settleman, Ph.D., Chief Scientific Officer, Oncology Research and Development, Pfizer
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Dr Pant on the Potential Significance of Daraxonrasib for PDAC Management
2
Dr Akhade on Building the Evidence Base for Low-Dose Immunotherapy
3
FDA Accepts NDA for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer
4
EGFR PACC Mutations Define a Distinct NSCLC Subclass With Growing Treatment Options
5